Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Walgreens Retains Boots Business Ownership Amid Market Instability

Walgreens Boots Alliance Inc (NASDAQ:WBA) has decided to retain its Boots and No7 Beauty Company businesses under its existing ownership. The decision marks the conclusion of the review that began in January. The discussions Walgreens had with potential buyers did not yield expected results as the recent market instability severely impacted the financial availability…

Markets Open Higher; US Goods Gap Narrows To $104.3B In May

Markets Open Higher; US Goods Gap Narrows To $104.3B In May

U.S. stocks traded higher this morning, with the Dow Jones gaining over 350 points on Tuesday.

Looking Into VistaGen Therapeutics's Return On Capital Employed

Looking Into VistaGen Therapeutics's Return On Capital Employed

Benzinga Pro data, VistaGen Therapeutics (NASDAQ:VTGN) reported Q4 sales of $38.90 thousand. Earnings fell to a loss of $16.69 million, resulting in a 58.41% decrease from last quarter.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Smith & Wesson Brands's Return On Capital Employed Overview

According to Benzinga Pro, during Q4, Smith & Wesson Brands (NASDAQ:SWBI) earned $36.13 million, a 18.31% increase from the preceding quarter. Smith & Wesson Brands also posted a total of $181.30 million in sales, a 2.0% increase since Q3.

RF Industries's Return on Invested Capital Insights

According to Benzinga Pro, during Q2, RF Industries (NASDAQ:RFIL) earned $503.00 thousand, a 281.59% increase from the preceding quarter. RF Industries also posted a total of $21.50 million in sales, a 27.11% increase since Q1.

Looking Into Global Blood Therapeutics's Return On Capital Employed

According to Benzinga Pro data, during Q1, Global Blood Therapeutics (NASDAQ:GBT) posted sales of $55.16 million. Earnings were up 7.03%, but Global Blood Therapeutics still reported an overall loss of $81.42 million.

Hooker Furniture Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q1, Hooker Furniture (NASDAQ:HOFT) earned $3.18 million, a 180.09% increase from the preceding quarter. Hooker Furniture also posted a total of $147.31 million in sales, a 9.28% increase since Q4.

inkl

Read news from The Economist, FT, and more,
with one subscription

Roivant, Pfizer Unveil Latest Spinout Focused On Autoimmune Diseases

Roivant, Pfizer Unveil Latest Spinout Focused On Autoimmune Diseases

Roivant Sciences Ltd (NASDAQ:ROIV) and Pfizer Inc (NYSE:PFE) unveiled Priovant Therapeutics, dedicated to developing and commercializing novel therapies for autoimmune diseases. Priovant was established in September 2021 through a transaction between Roivant and Pfizer. Pfizer licensed oral and topical brepocitinib's global development rights and US and Japan commercial rights to Priovant. Pfizer holds a 25%…

Tencent Targets Metaverse After Overseas Opportunities, EV To Drive Growth

Tencent Targets Metaverse After Overseas Opportunities, EV To Drive Growth

Tencent Holding Ltd (OTC:TCEHY) acknowledged setting up a unit focused on exploring the space to tap multiple opportunities in extended reality (XR) technologies in the next 4-5 years, Reuters reports. Gaming chief Steven Ma disclosed that Tencent had set up an XR business line to combine hardware and software, betting on most…

Velodyne Shares Pop Post Multi-Year Agreement With Mobile Robotics Leader

Velodyne Shares Pop Post Multi-Year Agreement With Mobile Robotics Leader

Velodyne Lidar, Inc (NASDAQ: VLDR) forged a multi-year deal for its lidar sensors with Boston Dynamics, the global leader in mobile robotics. Boston Dynamics chose Velodyne's sensors to provide perception and navigation capabilities for its highly mobile robots. Velodyne's lidar sensor solutions enable mobile robots to operate autonomously and safely. They provide real-time 3D…

Analyst Ratings for Karuna Therapeutics

Analyst Ratings for Karuna Therapeutics

Analysts have provided the following ratings for Karuna Therapeutics (NASDAQ:KRTX) within the last quarter:

Where Aspen Technology Stands With Analysts

Where Aspen Technology Stands With Analysts

Within the last quarter, Aspen Technology (NASDAQ:AZPN) has observed the following analyst ratings:

Why Trip.com Shares Are Surging Today

Why Trip.com Shares Are Surging Today

Trip.com Group Ltd (NASDAQ:TCOM) said its first-quarter FY22 sales remained flat year-on-year at RMB4.1 billion ($649 million). Net revenue decreased by 12% Q/Q. The sequential decrease was caused by the impact of the latest wave of COVID-19 resurgence in China. Accommodation reservation revenue fell 8% Y/Y, transportation ticketing increased 10%, packaged tours revenue…

Surging Gas Prices Make Tesla An Attractive Option For Some Uber, Lyft Drivers - Read How

Surging Gas Prices Make Tesla An Attractive Option For Some Uber, Lyft Drivers - Read How

Some Uber Technologies, Inc (NYSE: UBER) and Lyft, Inc (NASDAQ: LYFT) drivers found renting or buying a Tesla, Inc (NASDAQ:

Get all your
news in one place.

100's of premium titles.
One news app.

Analyst Ratings for Microchip Technology

Within the last quarter, Microchip Technology (NASDAQ:MCHP) has observed the following analyst ratings:

Ideaya Nominates Potential First-In-Class Pol Theta Helicase Inhibitor In Collaboration With GSK

Ideaya Biosciences Inc (NASDAQ:IDYA) has selected a potential first-in-class Pol Theta Helicase development candidate, a small molecule inhibitor of the helicase domain of DNA Polymerase Theta. Ideaya is collaborating with GSK plc (NYSE:GSK) on IND-enabling studies to support the evaluation of the Pol Theta Helicase candidate in combination with niraparib, GSK's PARP inhibitor, in tumors with…

JetBlue Won't Take No For An Answer, Makes Another Bid For Spirit Airlines

If anything can be said about JetBlue Airways (NASDAQ: JBLU), it would be that it doesn't easily give up. The airline has offered yet another upgrade to its acquisition bid for Spirit Airlines Inc.

Here's Why Cognyte Software Shares Are Crashing Premarket

Cognyte Software Ltd (NASDAQ:CGNT) reported a first-quarter FY23 non-GAAP revenue decline of 24.7% year-on-year to $86.7 million, missing the consensus of $112.6 million. Segments: Software revenue declined by 51.8% Y/Y to $24.9 million. Software service revenue fell 9.7% Y/Y to $45.8 million. Professional service and other revenue increased 27.8% Y/Y to $15.7 million. The…

Get all your
news in one place.

100's of premium titles.
One news app.

Read Why Playtika's Shares Are Trading Higher Premarket

Playtika Holding Corp (NASDAQ: PLTK) shares are soaring in the premarket session today on the news of the majority stake being acquired by Private equity firm Joffre Capital.

The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics' Tebipenem, Graybug Reviews Strategic Alternatives

Here's a roundup of top developments in the biotech space over the last 24 hours:

Why Evofem Biosciences Stock Is Surging Today

Evofem Biosciences Inc (NASDAQ: EVFM) shares are trading higher Tuesday after the company announced an agreement with a pharmacy benefit manager.

$100 Invested In Robinhood Right Now Would Be Worth This Much If It Hits Same Level As At Height Of Dogecoin Mania

Robinhood Markets, Inc. (NASDAQ: HOOD) rallied strongly on Monday amid rumors that cryptocurrency exchange FTX could be eyeing acquiring the trading app.

Intuit And 4 Other Stocks Insiders Are Selling

US stock futures traded higher this morning on Tuesday after recording a decline in the previous session. Investors, meanwhile, focused on some notable insider trades.

Benzinga Before The Bell: Roe vs Wade Ruling Effect, Airbnb's Ban on Parties, JetBlue's Modified Proposal And Other Top Financial Stories Tuesday, June 28

Canopy Growth - Cointreau Trademark Battle Ends, Fitch Ratings Downgrades Canopy Stock

Last year, the French alcohol maker Remy Cointreau (OTC: REMYY) sued Canopy Growth Corporation (NASDAQ: CGC) for alleged trademark infringement over its CBD-infused sparkling water brand Quatreau.

1 … 374 375 376 377

People

Vitalik Buterin

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Berkshire Hathaway

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Virtual reality

Places

374,913 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play